Evaluation of Traditional Laboratory Markers as Predictors of Renal Flares: A Post-hoc Analysis of Four Phase III Clinical Trials of SLE

被引：0
作者：
Jagerback, Sandra [1 ]
Gomez, Alvaro [1 ]
Parodis, Ioannis [2 ]
机构：
[1] Karolinska Inst, Div Rheumatol, Dept Med, Stockholm, Sweden
[2] Karolinska Inst, Stockholm, Sweden
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0540
引用
收藏
页码：1090 / 1093
页数：4
相关论文
共 50 条
  • [41] Oteseconazole for RVVC in diabetes: post-hoc analysis of safety and clinical response in phase 3 studies
    Nyirjesy, P.
    Sobel, J. D.
    Degenhardt, T.
    Weclaw, C.
    Person, K.
    Mcgaurn, S.
    Brand, S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (02) : S784 - S784
  • [42] PREDICTORS OF SUSTAINABILITY OF RESPONSE WITH CENOBAMATE: POST-HOC SUBSET ANALYSIS OF A PHASE 3, OPEN-LABEL STUDY
    Stern, S.
    Wechsler, R.
    Kerr, W.
    Wade, C.
    Vossler, D. G.
    Rosenfeld, W. E.
    VALUE IN HEALTH, 2023, 26 (06) : S17 - S17
  • [43] Post-hoc Analysis of the Effects of Belimumab on Musculoskeletal Organ Manifestations in BILAG in the Phase-3-Trials with Belimumab
    Hiepe, F.
    Fischer-Betz, R.
    Schwarting, A.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 142 - 143
  • [44] Advanced extrahepatic cholangiocarcinoma: Post-hoc analysis of the ABC-01,-02 and-03 clinical trials
    Lamarca, A.
    Ross, P. J.
    Wasan, H. S.
    Hubner, R.
    McNamara, M. G.
    Lopes, A.
    Palmer, D.
    Valle, J. W.
    Bridgewater, J. A.
    ANNALS OF ONCOLOGY, 2023, 34 : S215 - S215
  • [45] OUTCOMES OF PASSABLE AND NON-PASSABLE STRICTURES IN CLINICAL TRIALS OF CROHN'S DISEASE: A POST-HOC ANALYSIS
    Narula, Neeraj
    Wong, Emily C.
    Dulai, Parambir
    Marshall, John K.
    Colombel, Jean Frederic
    Reinisch, Walter
    GASTROENTEROLOGY, 2021, 160 (06) : S517 - S517
  • [46] Safety and tolerability of atogepant: A post hoc analysis of pooled data from four clinical trials
    Rizzoli, P.
    Marmura, M. J.
    Robblee, J.
    McVige, J. W.
    Sacco, S. E.
    Ferreira, R.
    Rekeda, L.
    Ma, J.
    Dabruzzo, B. L.
    Ashina, M.
    HEADACHE, 2022, 62 : 121 - 122
  • [47] Efficacy, safety, and tolerability of brivaracetam with concomitant lamotrigine or concomitant topiramate in pooled Phase III randomized, double-blind trials: A post-hoc analysis
    Benbadis, Selim
    Klein, Pavel
    Schiemann, Jimmy
    Diaz, Anyzeila
    Elmoufti, Sami
    Whitesides, John
    EPILEPSY & BEHAVIOR, 2018, 80 : 129 - 134
  • [48] Safety and tolerability of atogepant: a post hoc analysis of pooled data from four clinical trials
    Rizzoli, P.
    Marmura, M.
    Robblee, J.
    McVige, J.
    Sacco, S.
    Ferreira, R. De Abreu
    Rekeda, L.
    Ma, J.
    Dabruzzo, B.
    Ashina, M.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1)
  • [49] Dulaglutide treatment reduces glycaemic excursions in people with type 2 diabetes: a post-hoc analysis of 6 phase 3 randomised clinical trials
    Pechtner, V.
    Charpentier, G.
    Garcia-Perez, L. -E.
    Thieu, V. T.
    Jia, N.
    Jacobson, J. G.
    DIABETOLOGIA, 2017, 60 : S386 - S386
  • [50] Dulaglutide Treatment Reduces Glycemic Excursions in People with Type 2 Diabetes: A Post-hoc Analysis of Six Phase 3 Randomized Clinical Trials
    Charpentier, Guillaume
    Garcia-Perez, Luis E.
    Thieu, Vivian T.
    Jia, Nan
    Jacobson, Jennie G.
    Pechtner, Valeria
    DIABETES, 2017, 66 : A623 - A623
12345